1190380-64-3 Usage
General Description
1-Cyclobutyl-1H-pyrazol-4-ylamine is a chemical compound with the molecular formula C7H10N2. It is a pyrazole derivative that contains a cyclobutyl group attached to the nitrogen atom of the pyrazole ring. 1-Cyclobutyl-1H-pyrazol-4-ylaMine is primarily used in the pharmaceutical industry as an intermediate for the synthesis of various biologically active molecules. It has potential applications in drug discovery and development, particularly in the research and design of new medications for the treatment of various diseases. Additionally, it may also have uses in other fields such as agrochemicals and materials science. Overall, 1-Cyclobutyl-1H-pyrazol-4-ylamine is a versatile chemical with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1190380-64-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,3,8 and 0 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1190380-64:
(9*1)+(8*1)+(7*9)+(6*0)+(5*3)+(4*8)+(3*0)+(2*6)+(1*4)=143
143 % 10 = 3
So 1190380-64-3 is a valid CAS Registry Number.
1190380-64-3Relevant articles and documents
2-substituted parazoleamino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof
-
Paragraph 0097; 0098; 0100, (2019/04/10)
The invention relates to a series of new compounds as a JAK inhibitor, as well as compositions and applications thereof, and particularly provides a series of compounds (I) that have a strong JAK inhibiting activity, or stereisomers, geometrical isomers, tautomers, pharmaceutically acceptable salts, prodrugs, metabolites, isotope derivatives, and solvates, as well as medicine compositions comprising such compounds. The invention also discloses applications of the compounds or the medicine compositions in preparation of a medicine, which is used for treatment of autoimmune diseases or cancer.
PYRIMIDINE INHIBITORS OF KINASES
-
, (2010/12/29)
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A1, A2, A3, A4, X and Y are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.
